当前位置:
X-MOL 学术
›
Cell Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A Sympathetic Treatment for Obesity.
Cell Metabolism ( IF 27.7 ) Pub Date : 2020-06-02 , DOI: 10.1016/j.cmet.2020.05.009 Jung Dae Kim 1 , Sabrina Diano 2
中文翻译:
肥胖的同情疗法。
更新日期:2020-06-02
Cell Metabolism ( IF 27.7 ) Pub Date : 2020-06-02 , DOI: 10.1016/j.cmet.2020.05.009 Jung Dae Kim 1 , Sabrina Diano 2
Affiliation
Amphetamine (AMPH), mainly used in the treatment of attention deficit hyperactivity disorder and narcolepsy, has weight loss properties, although with detrimental cardiovascular effects. In this issue, Mahú et al. (2020) describe the effect of a new derivative of AMPH, “PEGyAMPH,” a brain-spared anti-obesity drug that alters sympathetic activity without cardiovascular side effects.
中文翻译:
肥胖的同情疗法。
苯丙胺(AMPH)主要用于治疗注意力不足过动症和发作性睡病,尽管具有有害的心血管作用,但仍具有减肥作用。在本期中,Mahú等人。(2020年)描述了AMPH的新衍生物“ PEGyAMPH”的作用,这是一种大脑保留的抗肥胖药,可改变交感神经活动而无心血管副作用。